[Form 4] Fidelity National Financial, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Fidelity National Financial (FNF) reported an insider equity grant on a Form 4. The reporting person, a Director and Executive Vice‑Chairman, acquired 55,653 shares of restricted common stock on 11/10/2025 at $0 under transaction code A.

The award vests in three equal annual installments beginning November 10, 2026, subject to performance criteria in the award agreement. Following the transaction, beneficial holdings were 200,387.2675 shares direct, plus 565.2 indirect via a 401(k) account and 2,150,955 indirect via the Quirk 2002 Trust.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

QUIRK RAYMOND R

(Last) (First) (Middle)

601 RIVERSIDE AVENUE

(Street)

JACKSONVILLE FL 32204

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Fidelity National Financial, Inc. [ FNF ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Executive Vice-Chairman

3. Date of Earliest Transaction (Month/Day/Year)
11/10/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/10/2025		A		55,653(1)	A	$0	200,387.2675	D
Common Stock								565.2	I	401(k) account
Common Stock								2,150,955	I	Quirk 2002 Trust
Common Stock								0	I	Raymond Quirk 2004 Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Grant of restricted common stock vesting in three equal annual installments beginning November 10, 2026, subject to the achievement of performance criteria specified in the reporting person's award agreement.

	/s/ Colleen E. Haley, as attorney-in-fact	11/12/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did FNF disclose on this Form 4?

An insider who is a Director and Executive Vice‑Chairman acquired 55,653 shares of restricted common stock at $0 on 11/10/2025.

How do the restricted shares vest for FNF's insider grant?

They vest in three equal annual installments beginning November 10, 2026, subject to performance criteria in the award agreement.

What are the insider's FNF holdings after the transaction?

Post-transaction, holdings were 200,387.2675 shares direct, 565.2 shares indirect via a 401(k), and 2,150,955 shares indirect via the Quirk 2002 Trust.

What transaction code was used on the FNF Form 4?

Transaction code A, indicating an acquisition, with a price of $0 (grant).

What roles does the reporting person hold at FNF (ticker FNF)?

The reporting person is a Director and an Officer, serving as Executive Vice‑Chairman.

Does the filing mention derivative securities?

Table II shows no derivative securities acquired or disposed in this transaction.